Saracino, Amanda M.
Kelberman, Daniel
Otto, Georg W.
Gagunashvili, Andrey
Abraham, David J.
Denton, Christopher P.
Funding for this research was provided by:
Rosetrees Trust
Royal Free Charity
Skin Health Institute of Victoria, Australia
Australasian College of Dermatologists
Dermatrust
National Institute for Health Research
Versus Arthritis
Article History
Received: 24 November 2022
Revised: 24 November 2022
Accepted: 16 January 2023
First Online: 13 March 2023
Declarations
:
: AMS: has received honoraria from UCB outside the submitted work. DK: nil. GWO: nil. AG: nil. DJA: nil. CPD: reports personal fees or research grants to his institution from GlaxoSmithKline, Galapagos, Boehringer Ingelheim, Roche, CSL Behring, Corbus, Horizon, and Arxx Therapeutics outside the submitted work.
: This study was approved by the National Research Ethics Service (London-Hampstead, MREC Reference 6398). Tissue specimens were obtained with written informed consent as part of an ongoing programme of research into the pathogenesis of scleroderma.
: Written informed consent to participate in the study and publication was obtained from all participants.